Ulmer JB - Search Results

1

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM. Dupuis M, et al. Among authors: ulmer jb. J Immunol. 2000 Sep 1;165(5):2850-8. doi: 10.4049/jimmunol.165.5.2850. J Immunol. 2000. PMID: 10946318

2

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.

Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O'Hagan D, Ulmer JB, Donnelly JJ, McDonald DM, Ott G. Denis-Mize KS, et al. Among authors: ulmer jb. Gene Ther. 2000 Dec;7(24):2105-12. doi: 10.1038/sj.gt.3301347. Gene Ther. 2000. PMID: 11223992

3

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, Otten GR, Thudium K, Selby MJ, Ulmer JB. Widera G, et al. Among authors: ulmer jb. J Immunol. 2000 May 1;164(9):4635-40. doi: 10.4049/jimmunol.164.9.4635. J Immunol. 2000. PMID: 10779767

4

Enhancement of DNA vaccine potency by electroporation in vivo.

Selby M, Goldbeck C, Pertile T, Walsh R, Ulmer J. Selby M, et al. J Biotechnol. 2000 Sep 29;83(1-2):147-52. doi: 10.1016/s0168-1656(00)00308-4. J Biotechnol. 2000. PMID: 11000470

5

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.

zur Megede J, Otten GR, Doe B, Liu H, Leung L, Ulmer JB, Donnelly JJ, Barnett SW. zur Megede J, et al. Among authors: ulmer jb. J Virol. 2003 Jun;77(11):6197-207. doi: 10.1128/jvi.77.11.6197-6207.2003. J Virol. 2003. PMID: 12743276 Free PMC article.

6

Technical and regulatory hurdles for DNA vaccines.

Donnelly J, Berry K, Ulmer JB. Donnelly J, et al. Among authors: ulmer jb. Int J Parasitol. 2003 May;33(5-6):457-67. doi: 10.1016/s0020-7519(03)00056-0. Int J Parasitol. 2003. PMID: 12782047 Review.

7

Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.

Otten GR, Schaefer M, Doe B, Liu H, Megede JZ, Donnelly J, Rabussay D, Barnett S, Ulmer JB. Otten GR, et al. Among authors: ulmer jb. Vaccine. 2006 May 22;24(21):4503-9. doi: 10.1016/j.vaccine.2005.08.017. Epub 2005 Aug 19. Vaccine. 2006. PMID: 16181711

8

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.

Megede JZ, Otten GR, Doe B, Liu H, Srivastava R, Greer C, Legg H, Tang T, Polo JM, Donnelly JJ, Ulmer JB, Barnett SW. Megede JZ, et al. Among authors: ulmer jb. Vaccine. 2006 Apr 5;24(15):2755-63. doi: 10.1016/j.vaccine.2006.01.013. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16460840

9

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA. Ulmer JB, et al. Vaccine. 1994 Dec;12(16):1541-4. doi: 10.1016/0264-410x(94)90081-7. Vaccine. 1994. PMID: 7879422

10

Toward the development of DNA vaccines.

Ulmer JB, Donnelly JJ, Liu MA. Ulmer JB, et al. Curr Opin Biotechnol. 1996 Dec;7(6):653-8. doi: 10.1016/s0958-1669(96)80078-4. Curr Opin Biotechnol. 1996. PMID: 8939639 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters